SBI US Gateway Fund
Funding rounds backed by SBI US Gateway Fund.
- Funding disclosed in full
- $3.7M
- Median round
- $3.7M
- Rounds in calculation
- 1
| Company | Round | Market | Investors | Announced | Details |
|---|---|---|---|---|---|
| Sift Biosciences Develops next-generation peptide immunotherapy platform using AI metagenomics and high-throughput profiling to engage memory T cells for cancer and autoimmune diseases | $3.7MPre-Seed | BiotechUnited States |